Switching from
your current provider.

If you are running an established brand on another clinical infrastructure provider, you already know what good looks like. This page covers the specific things that make switching to Beluga straightforward, and the lock in failure modes that cause partners to switch to us in the first place.
30-minute scoping call. You stay on your current platform until cutover.

Three lock-in failure modes
that drive brands to switch.

Own your customers and your payments.
Some clinical infrastructure providers require you to use their merchant account, which means they hold your payment tokens, your customer relationships, and your leverage to switch. Beluga lets you bring your own merchant, your own Stripe, your own gateway. You own your customers and your payments.
Choose your pharmacies, see your costs.
Some providers force you into their pharmacy network with no visibility into pricing or routing logic. Beluga lets you bring your own pharmacy, use ours, or mix and match per medication and per state. You see the costs. You choose the providers.
See pricing before you integrate.
Some providers will not show you full pricing until you have integrated, at which point switching is expensive. Beluga shares the complete pricing structure during the scoping call, before integration begins. You see per visit pricing, pass through pharmacy costs, and the full economic picture before you sign anything. We take no revenue cut from your customers and do not add fees after integration.

What switching
looks like.

Three phases over 4-6 weeks. Your existing provider keeps serving traffic until cutover, so there is no downtime and no disruption to existing patient relationships.

What's different

about Beluga.

Your merchant account stays yours. We never hold your payment token.
Your pharmacy can stay yours, use ours, or you can run both per medication and per state.
Conversion-optimized intake. No photo ID upload. No full body photos for GLP-1 visits.
Physicians only, average 35+ state licenses each.
Insurance-credentialed nationally if you need it.
Profitable since 2020. No investor exit pressure shaping the roadmap.
Scope a migration →